Yu. M. Stepanov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yu. M. Stepanov has a total of 87 co-authors. Here are the top co-authors by number of shared publications:
- Oksana Petishko
Institute of Gastroenterology of NAMSU, Dnipro, Ukraine
23 shared publications - I. A. Klenina
State Institution “Institute of Gastroenterology of the National Academy of Medical Sciences of Ukraine”, Dnipro, Ukraine
18 shared publications - O. M. Tatarchuk
State Institution “Institute of Gastroenterology of the National Academy of Medical Sciences of Ukraine”, Dnipro, Ukraine
18 shared publications - Natalia Zavhorodnia
State Institution “Institute of Gastroenterology of the National Academy of Medical Sciences of Ukraine”, Dnipro, Ukraine
12 shared publications - I.YA. Budzak
Dnipro State Medical University, Dnipro, Ukraine
8 shared publications - L. M. Mosiichuk
State Institution “Institute of Gastroenterology of the National Academy of Medical Sciences of Ukraine”, Dnipro, Ukraine
8 shared publications
Latest Publications
- Open Access
- 29 September 2026
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 60 (3) , 213-223
1
Background. Autoimmune gastritis (AIG) is a chronic immune-mediated disease characterized by the destruction of the acid-producing gastric mucosa, which is caused by the formation of autoantibodies to parietal cells and/or intrinsic factor, leading to atrophy of the acid-producing CO, hypo-/achlorhydria in the stomach, impaired absorption of vitamin B12, iron, the development of pernicious anemia, and an increased risk of neuroendocrine tumors. Diagnosis of AIG may be delayed and difficult, as gastric symptoms are mild and endoscopic and histological findings are nonspecific in the early stages. The purpose of the work is to analyze the modern scientific literature on AIG and to determine the problems of diagnosis and management of patients with AIG with different course variants using clinical cases as an example. Materials and methods. Two of our own clinical observations are presented. Clinical case 1: a 60-year-old woman with dyspeptic symptoms was observed for a long time with a diagnosis of atrophic gastritis, and only after 8 years, a diagnosis of AIG was established. Clinical case 2 was a 42-year-old woman with a history of severe anemia, atrophic gastritis, and recurrent neuroendocrine (carcinoid) tumors of the stomach; only after 5 years, a diagnosis of AIH was made. A detailed analysis and discussion of clinical cases were conducted. Conclusions. Autoimmune gastritis is a disease that worsens the quality of life of patients and is often diagnosed late, as evidenced by the two clinical cases. The presence of anemia, dyspeptic complaints, concomitant autoimmune diseases (primarily of thyroid gland), neurological disorders requires the exclusion of AIG in a patient. Timely diagnosis of AIG is important for the prevention and effective treatment of its clinical manifestations and possible adverse consequences. Management of patients with AIG consists of more careful endoscopic and morphological observation for the timely detection of complications such as neuroendocrine tumors, precancerous changes, and gastric cancer.
- 29 September 2026
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 60 (3) , 213-223
Open Access1
Background. Autoimmune gastritis (AIG) is a chronic immune-mediated disease characterized by the destruction of the acid-producing gastric mucosa, which is caused by the formation of autoantibodies to parietal cells and/or intrinsic factor, leading to atrophy of the acid-producing CO, hypo-/achlorhydria in the stomach, impaired absorption of vitamin B12, iron, the development of pernicious anemia, and an increased risk of neuroendocrine tumors. Diagnosis of AIG may be delayed and difficult, as gastric symptoms are mild and endoscopic and histological findings are nonspecific in the early stages. The purpose of the work is to analyze the modern scientific literature on AIG and to determine the problems of diagnosis and management of patients with AIG with different course variants using clinical cases as an example. Materials and methods. Two of our own clinical observations are presented. Clinical case 1: a 60-year-old woman with dyspeptic symptoms was observed for a long time with a diagnosis of atrophic gastritis, and only after 8 years, a diagnosis of AIG was established. Clinical case 2 was a 42-year-old woman with a history of severe anemia, atrophic gastritis, and recurrent neuroendocrine (carcinoid) tumors of the stomach; only after 5 years, a diagnosis of AIH was made. A detailed analysis and discussion of clinical cases were conducted. Conclusions. Autoimmune gastritis is a disease that worsens the quality of life of patients and is often diagnosed late, as evidenced by the two clinical cases. The presence of anemia, dyspeptic complaints, concomitant autoimmune diseases (primarily of thyroid gland), neurological disorders requires the exclusion of AIG in a patient. Timely diagnosis of AIG is important for the prevention and effective treatment of its clinical manifestations and possible adverse consequences. Management of patients with AIG consists of more careful endoscopic and morphological observation for the timely detection of complications such as neuroendocrine tumors, precancerous changes, and gastric cancer.
- Open Access
- 27 May 2026
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 60 (2) , 118-125
Correction of functional gastrointestinal disorders using Aqua Myrgorod Detox mineral water
The article presents the results of a study on the effectiveness of the therapeutic use of Aqua Myrgorod Detox mineral water in patients with functional diseases of the digestive system. Twenty-nine patients with functional gastrointestinal disorders were involved in the study. The use of Aqua Myrgorod Detox mineral water leads to a decrease in symptoms in patients with functional dyspepsia: the average score of epigastric pain decreased from 3.33 to 0.67, nausea — from 1.78 to 0.11, heartburn — from 2.44 to 0.22. Analysis of pH monitoring data showed the absence of a significant effect of Aqua Myrgorod Detox mineral water on intragastric and intraesophageal pH. The use of mineral water in patients with biliary dysfunction led to the elimination of bitterness in the mouth and nausea, and a decrease in pain in the right hypochondrium. A single intake of Aqua Myrgorod Detox mineral water in biliary dysfunction contributes to the contraction of the gallbladder: 10 minutes after taking the water, the average contraction of the gallbladder was 17.8 %, after 50 minutes — 47.4 %. With functional constipation, there was a positive effect of mineral water on the frequency and consistency of stool in 90.0 % of patients. Aqua Myrgorod Detox mineral water can be recommended for practical use in the treatment and prevention of functional gastrointestinal disorders.
- 27 May 2026
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 60 (2) , 118-125
Open AccessCorrection of functional gastrointestinal disorders using Aqua Myrgorod Detox mineral water
The article presents the results of a study on the effectiveness of the therapeutic use of Aqua Myrgorod Detox mineral water in patients with functional diseases of the digestive system. Twenty-nine patients with functional gastrointestinal disorders were involved in the study. The use of Aqua Myrgorod Detox mineral water leads to a decrease in symptoms in patients with functional dyspepsia: the average score of epigastric pain decreased from 3.33 to 0.67, nausea — from 1.78 to 0.11, heartburn — from 2.44 to 0.22. Analysis of pH monitoring data showed the absence of a significant effect of Aqua Myrgorod Detox mineral water on intragastric and intraesophageal pH. The use of mineral water in patients with biliary dysfunction led to the elimination of bitterness in the mouth and nausea, and a decrease in pain in the right hypochondrium. A single intake of Aqua Myrgorod Detox mineral water in biliary dysfunction contributes to the contraction of the gallbladder: 10 minutes after taking the water, the average contraction of the gallbladder was 17.8 %, after 50 minutes — 47.4 %. With functional constipation, there was a positive effect of mineral water on the frequency and consistency of stool in 90.0 % of patients. Aqua Myrgorod Detox mineral water can be recommended for practical use in the treatment and prevention of functional gastrointestinal disorders.
- Open Access
- 27 March 2026
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 60 (1) , 52-67
Hepatocellular carcinoma: current aspects of multidisciplinary management. Part 2. Treatment and prevention
Hepatocellular carcinoma remains one of the most common causes of cancer-related mortality worldwide and represents a typical complication of chronic liver diseases. The complex interaction between tumor growth characteristics, liver functional capacity, comorbidities, and environmental factors necessitates a comprehensive multidisciplinary approach to the management of these patients. At the same time, modern strategies for the treatment and prevention of hepatocellular carcinoma should be based on the integration of clinical, laboratory, and instrumental data. This narrative review summarizes current approaches to the treatment and prevention of hepatocellular carcinoma with an emphasis on interdisciplinary clinical decision-making. A systematic literature search was conducted using the PubMed/Medline, Scopus, Web of Science, Cochrane Library, Google Scholar, Embase, Web of Knowledge Science Citation Index, and BIOSIS databases, employing keywords related to the treatment, prevention, and prognosis of hepatocellular carcinoma. The analysis included review articles, international clinical practice guidelines, and key clinical trial results published predominantly over the past five years. The review presents current principles of disease staging, methods for assessing liver functional reserve and overall patient condition and outlines the role of the multidisciplinary team in selecting optimal treatment strategies. Indications for surgical treatment, the use of locoregional therapies, and systemic treatment options are discussed in detail, and the evolution of systemic therapy from targeted agents to modern combination immunotherapy is highlighted. A separate section is devoted to strategies for the prevention of hepatocellular carcinoma, including immunoprophylaxis, monitoring the effectiveness of treatment for chronic viral hepatitis, reduction of toxic and metabolic risk factors, and surveillance after curative treatment. Thus, a comprehensive approach to the treatment and prevention of hepatocellular carcinoma improves patient survival and quality of life and reduces the risk of disease recurrence.
- 27 March 2026
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 60 (1) , 52-67
Open AccessHepatocellular carcinoma: current aspects of multidisciplinary management. Part 2. Treatment and prevention
Hepatocellular carcinoma remains one of the most common causes of cancer-related mortality worldwide and represents a typical complication of chronic liver diseases. The complex interaction between tumor growth characteristics, liver functional capacity, comorbidities, and environmental factors necessitates a comprehensive multidisciplinary approach to the management of these patients. At the same time, modern strategies for the treatment and prevention of hepatocellular carcinoma should be based on the integration of clinical, laboratory, and instrumental data. This narrative review summarizes current approaches to the treatment and prevention of hepatocellular carcinoma with an emphasis on interdisciplinary clinical decision-making. A systematic literature search was conducted using the PubMed/Medline, Scopus, Web of Science, Cochrane Library, Google Scholar, Embase, Web of Knowledge Science Citation Index, and BIOSIS databases, employing keywords related to the treatment, prevention, and prognosis of hepatocellular carcinoma. The analysis included review articles, international clinical practice guidelines, and key clinical trial results published predominantly over the past five years. The review presents current principles of disease staging, methods for assessing liver functional reserve and overall patient condition and outlines the role of the multidisciplinary team in selecting optimal treatment strategies. Indications for surgical treatment, the use of locoregional therapies, and systemic treatment options are discussed in detail, and the evolution of systemic therapy from targeted agents to modern combination immunotherapy is highlighted. A separate section is devoted to strategies for the prevention of hepatocellular carcinoma, including immunoprophylaxis, monitoring the effectiveness of treatment for chronic viral hepatitis, reduction of toxic and metabolic risk factors, and surveillance after curative treatment. Thus, a comprehensive approach to the treatment and prevention of hepatocellular carcinoma improves patient survival and quality of life and reduces the risk of disease recurrence.
- Open Access
- 20 December 2025
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 59 (4) , 283-288
A complex clinical case of hiatal hernia with Cameron syndrome
Hiatal hernia (HH) is a pathological condition in which part of the stomach, and sometimes other abdominal organs, are displaced through the esophageal hiatus into the chest cavity. The occurrence of HH is associated with weakening of the ligamentous apparatus of the diaphragm, increased intra-abdominal pressure, and age-related degenerative changes in tissues. The disease is often complicated by the development of gastroesophageal reflux disease, esophagitis, and ulcers of the esophageal mucosa. Rare complications include esophageal strictures, Barrett’s esophagus, hernia incarceration or perforation, as well as difficult-to-diagnose gastric mucosal ulcers in the hernial sac (Cameron syndrome), which may be accompanied by chronic bleeding and iron deficiency anemia. Cameron syndrome is an erosive-ulcerative lesion of the gastric mucosa in the area of hernial protrusion in HH, accompanied by chronic or overt bleeding and the development of iron deficiency anemia. These lesions are of particular clinical significance because they can cause both prolonged occult blood loss and acute, life-threatening bleeding. Lesions of the mucous membrane of the upper gastrointestinal tract are often underestimated or misinterpreted during standard examination, which increases the risk of misdiagnosis and selection of inadequate treatment in patients with Cameron syndrome. The article discusses a case of Cameron syndrome diagnosis in a patient with HH.
- 20 December 2025
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 59 (4) , 283-288
Open AccessA complex clinical case of hiatal hernia with Cameron syndrome
Hiatal hernia (HH) is a pathological condition in which part of the stomach, and sometimes other abdominal organs, are displaced through the esophageal hiatus into the chest cavity. The occurrence of HH is associated with weakening of the ligamentous apparatus of the diaphragm, increased intra-abdominal pressure, and age-related degenerative changes in tissues. The disease is often complicated by the development of gastroesophageal reflux disease, esophagitis, and ulcers of the esophageal mucosa. Rare complications include esophageal strictures, Barrett’s esophagus, hernia incarceration or perforation, as well as difficult-to-diagnose gastric mucosal ulcers in the hernial sac (Cameron syndrome), which may be accompanied by chronic bleeding and iron deficiency anemia. Cameron syndrome is an erosive-ulcerative lesion of the gastric mucosa in the area of hernial protrusion in HH, accompanied by chronic or overt bleeding and the development of iron deficiency anemia. These lesions are of particular clinical significance because they can cause both prolonged occult blood loss and acute, life-threatening bleeding. Lesions of the mucous membrane of the upper gastrointestinal tract are often underestimated or misinterpreted during standard examination, which increases the risk of misdiagnosis and selection of inadequate treatment in patients with Cameron syndrome. The article discusses a case of Cameron syndrome diagnosis in a patient with HH.
- Open Access
- 29 September 2025
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 59 (3) , 235-242
The effect of Aqua Myrgorod Detox mineral water on the gallbladder motility and biochemical parameters of blood serum in patients with biliary dysfunction
Background. Functional biliary dysfunction is a common disorder of gallbladder motility and significantly reduces the quality of life of patients. Current therapeutic strategies remain limited, which emphasizes the need to find safe non-drug approaches. One of the promising areas is the use of mineral waters that can influence gallbladder motility, mineral balance, and oxidative stress processes. The aim is to evaluate the effect of Aqua Myrgorod Detox mineral water on gallbladder motility and serum biochemical parameters in patients with biliary dysfunction. Materials and methods. The study included 10 patients with biliary dysfunction (mean age was (48.0 ± 2.25) years). For 7–8 days, they received Aqua Myrgorod Detox mineral water in a dose of 200 ml three times a day. Before and after the course, a clinical examination, gallbladder ultrasound with determination of the volume and contractile function, as well as laboratory analysis of macro- (Ca, Mg, Na, K) and microelements (Cu, Fe) and lipid peroxidation products were performed. In addition, integral coefficients (Na/K, Ca/Mg, Cu/Fe, MDA/Mg) were calculated. Results. It was found that 10 minutes after taking mineral water, the gallbladder contraction was (19.36 ± 2.47) %, and after 50 minutes — (45.36 ± 3.02) %. After the course of therapy, all patients had bile homogenization and the disappearance of sludge. Biochemical indicators showed an increase in magnesium levels from (0.77 ± 0.04) to (0.87 ± 0.03) mmol/l, p = 0.017, a decrease in copper concentration from (19.80 ± 0.85) to (17.59 ± 0.68) μmol/l, p = 0.004, and a decrease in malondialdehyde levels from (6.63 ± 0.60) to (4.18 ± 0.30) μmol/l, p = 0.018. Correlation analysis revealed a significant decrease in the Ca/Mg (p = 0.039) and MDA/Mg ratio (p = 0.018), reflecting an increase in antioxidant potential. Conclusions. Aqua Myrgorod Detox mineral water has a pronounced cholekinetic effect, helps normalize bile echostructure, improves magnesium balance and reduces the severity of oxidative stress. A comprehensive analysis of biochemical indicators confirms the feasibility of its use as a non-drug approach in the treatment of patients with biliary dysfunction.
- 29 September 2025
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 59 (3) , 235-242
Open AccessThe effect of Aqua Myrgorod Detox mineral water on the gallbladder motility and biochemical parameters of blood serum in patients with biliary dysfunction
Background. Functional biliary dysfunction is a common disorder of gallbladder motility and significantly reduces the quality of life of patients. Current therapeutic strategies remain limited, which emphasizes the need to find safe non-drug approaches. One of the promising areas is the use of mineral waters that can influence gallbladder motility, mineral balance, and oxidative stress processes. The aim is to evaluate the effect of Aqua Myrgorod Detox mineral water on gallbladder motility and serum biochemical parameters in patients with biliary dysfunction. Materials and methods. The study included 10 patients with biliary dysfunction (mean age was (48.0 ± 2.25) years). For 7–8 days, they received Aqua Myrgorod Detox mineral water in a dose of 200 ml three times a day. Before and after the course, a clinical examination, gallbladder ultrasound with determination of the volume and contractile function, as well as laboratory analysis of macro- (Ca, Mg, Na, K) and microelements (Cu, Fe) and lipid peroxidation products were performed. In addition, integral coefficients (Na/K, Ca/Mg, Cu/Fe, MDA/Mg) were calculated. Results. It was found that 10 minutes after taking mineral water, the gallbladder contraction was (19.36 ± 2.47) %, and after 50 minutes — (45.36 ± 3.02) %. After the course of therapy, all patients had bile homogenization and the disappearance of sludge. Biochemical indicators showed an increase in magnesium levels from (0.77 ± 0.04) to (0.87 ± 0.03) mmol/l, p = 0.017, a decrease in copper concentration from (19.80 ± 0.85) to (17.59 ± 0.68) μmol/l, p = 0.004, and a decrease in malondialdehyde levels from (6.63 ± 0.60) to (4.18 ± 0.30) μmol/l, p = 0.018. Correlation analysis revealed a significant decrease in the Ca/Mg (p = 0.039) and MDA/Mg ratio (p = 0.018), reflecting an increase in antioxidant potential. Conclusions. Aqua Myrgorod Detox mineral water has a pronounced cholekinetic effect, helps normalize bile echostructure, improves magnesium balance and reduces the severity of oxidative stress. A comprehensive analysis of biochemical indicators confirms the feasibility of its use as a non-drug approach in the treatment of patients with biliary dysfunction.
- Open Access
- 29 September 2025
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 59 (3) , 206-220
Hepatocellular carcinoma: modern aspects of interdisciplinary management. Part 1. Epidemiology, risk factors, diagnosis
Hepatocellular carcinoma (HCC) is the most common variant of primary liver cancer, characterized by high mortality and unfavorable prognosis. Global incidence and mortality from HCC continue to rise despite progress in the treatment of viral hepatitis due to the increasing prevalence of metabolic dysfunction-associated steatotic liver disease and obesity. Based on the analysis of literature sources from the Pubmed, MedLine, The Cochrane Library, Embase databases, the review summarizes current data on the epidemiology, key risk factors, pathogenesis and molecular classification of HCC. Special attention is paid to modern approaches to diagnosis, in particular imaging methods, the Liver Imaging Reporting and Data System, the role of non-invasive biomarkers and morphological verification. The importance of screening programs in high-risk groups and timely interdisciplinary interaction is emphasized, which allows optimizing the strategy of patient management in accordance with international clinical guidelines.
- 29 September 2025
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 59 (3) , 206-220
Open AccessHepatocellular carcinoma: modern aspects of interdisciplinary management. Part 1. Epidemiology, risk factors, diagnosis
Hepatocellular carcinoma (HCC) is the most common variant of primary liver cancer, characterized by high mortality and unfavorable prognosis. Global incidence and mortality from HCC continue to rise despite progress in the treatment of viral hepatitis due to the increasing prevalence of metabolic dysfunction-associated steatotic liver disease and obesity. Based on the analysis of literature sources from the Pubmed, MedLine, The Cochrane Library, Embase databases, the review summarizes current data on the epidemiology, key risk factors, pathogenesis and molecular classification of HCC. Special attention is paid to modern approaches to diagnosis, in particular imaging methods, the Liver Imaging Reporting and Data System, the role of non-invasive biomarkers and morphological verification. The importance of screening programs in high-risk groups and timely interdisciplinary interaction is emphasized, which allows optimizing the strategy of patient management in accordance with international clinical guidelines.
- Open Access
- 27 June 2025
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 59 (2) , 129-137
The role of high-resolution manometry in the diagnosis of esophageal disorders (literature review and personal clinical observations)
At present, clinical gastroenterology utilizes a number of high-precision methods for functional diagnosis of the esophagus and stomach, among which high-resolution manometry (HRM) holds a prominent place. This innovative technique enables a detailed assessment of esophageal function, particularly the coordination of muscular contractions during swallowing and the effectiveness of the lower esophageal sphincter. HRM has established itself as an exceptionally effective method for detecting motor disorders such as achalasia, gastroesophageal reflux disease, diffuse esophageal spasm, as well as other functional abnormalities that may cause dysphagia or impair bolus transit. One of the key advantages of this technique is the use of high-density catheters equipped with numerous pressure sensors spaced approximately 1 cm apart. This allows for the creation of detailed topographic maps of pressure in the esophagus, which display real-time muscle contractions and peristaltic activity. The high spatial and temporal resolution of HRM makes it possible to identify even minimal motor abnormalities that previously remained undetected when using conventional diagnostic methods. A significant advancement offered by HRM is the improved diagnosis of achalasia, particularly through its differentiation into three relevant subtypes. This classification has direct clinical implications, as it enables the personalization of treatment strategies based on the specific subtype of disorder. In the context of gastroesophageal reflux disease, HRM allows for precise assessment of the lower esophageal sphincter function and diaphragmatic contribution, which is crucial for detecting weakness of the antireflux barrier. Additionally, the method facilitates the identification of coexisting peristaltic disorders, which may reduce esophageal ability to clear from refluxate effectively, thereby aggravating the clinical presentation of the disease. In summary, high-resolution manometry plays a central role among modern diagnostic tools in gastroenterology, offering high accuracy in identifying esophageal motor dysfunctions and contributing to the optimization of therapeutic strategies. Ultimately, this leads to improved patient outcomes and quality of life, enabling clinicians to make informed decisions based on objective functional assessments of the esophagus.
- 27 June 2025
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 59 (2) , 129-137
Open AccessThe role of high-resolution manometry in the diagnosis of esophageal disorders (literature review and personal clinical observations)
At present, clinical gastroenterology utilizes a number of high-precision methods for functional diagnosis of the esophagus and stomach, among which high-resolution manometry (HRM) holds a prominent place. This innovative technique enables a detailed assessment of esophageal function, particularly the coordination of muscular contractions during swallowing and the effectiveness of the lower esophageal sphincter. HRM has established itself as an exceptionally effective method for detecting motor disorders such as achalasia, gastroesophageal reflux disease, diffuse esophageal spasm, as well as other functional abnormalities that may cause dysphagia or impair bolus transit. One of the key advantages of this technique is the use of high-density catheters equipped with numerous pressure sensors spaced approximately 1 cm apart. This allows for the creation of detailed topographic maps of pressure in the esophagus, which display real-time muscle contractions and peristaltic activity. The high spatial and temporal resolution of HRM makes it possible to identify even minimal motor abnormalities that previously remained undetected when using conventional diagnostic methods. A significant advancement offered by HRM is the improved diagnosis of achalasia, particularly through its differentiation into three relevant subtypes. This classification has direct clinical implications, as it enables the personalization of treatment strategies based on the specific subtype of disorder. In the context of gastroesophageal reflux disease, HRM allows for precise assessment of the lower esophageal sphincter function and diaphragmatic contribution, which is crucial for detecting weakness of the antireflux barrier. Additionally, the method facilitates the identification of coexisting peristaltic disorders, which may reduce esophageal ability to clear from refluxate effectively, thereby aggravating the clinical presentation of the disease. In summary, high-resolution manometry plays a central role among modern diagnostic tools in gastroenterology, offering high accuracy in identifying esophageal motor dysfunctions and contributing to the optimization of therapeutic strategies. Ultimately, this leads to improved patient outcomes and quality of life, enabling clinicians to make informed decisions based on objective functional assessments of the esophagus.
- Open Access
- 27 June 2025
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 59 (2) , 114-120
Efficacy of liraglutide in patients with metabolic-associated steatotic liver disease in type 2 diabetes mellitus
Background. The increasing incidence of metabolism-associated steatotic liver disease (MASLD) and type 2 diabetes prompts physicians to improve strategies for the diagnosis, prevention, and treatment of these metabolic conditions. Objective: to investigate the effects of glucagon-like peptide-1 receptor agonist (arGLP-1) on the severity of metabolic disorders in patients with MASLD and type 2 diabetes mellitus in the dynamics of treatment. Materials and methods. The study included 30 patients aged (56.5 ± 7.8) years with MASLD and type 2 diabetes mellitus. They were prescribed liraglutide, a arGLP-1, with gradual titration to the maximum dose. To assess body composition, body composition analyzers TANITA BC-545N (Japan) were used. Serum levels of glucose, glycosylated hemoglobin (HbA1c), parameters of lipid and carbohydrate metabolism were determined. The atherogenic index was calculated according to the formula of W.T. Friedewald, the TyG, TyG-BMI, TyG-WC indices were calculated based on the obtained bioimpedance analysis data, as well as lipid and carbohydrate metabolism indicators. Statistical processing of the study results was carried out by methods of variation statistics using the software package StatSoft Statistica 10.0. Results. After treatment with arGLP-1, a significant decrease in serum glucose to physiological norm was observed in 26.7 % of patients, and a reduction in HbA1c levels — in 66.7 %. The therapy led to a reduction in body mass index in 28 (93.3 %) of 30 patients, in body fat percentage — in 25 (83.3 %), and the number of cases of visceral obesity decreased to 17 (56.7 %). After the use of arGLP-1, a positive trend was observed in the form of a 1.3-fold decrease in serum triglyceride levels to (1.64 ± 0.20) mmol/L versus (2.12 ± 0.25) mmol/L before treatment. Serum cholesterol, which was elevated in 11 patients, reduced in 6 cases after therapy. The use of liraglutide led to a reduction in the TyG, TyG-BMI, TyG-WC indices. Conclusions. In patients with MASLD and type 2 diabetes, treatment with liraglutide for 6 months contributed to a decrease in the amount of fat in body composition and a positive dynamics of carbohydrate and lipid metabolism. The determination of the TyG index is a useful indicator for assessing insulin resistance, and the TyG-BMI and TyG-WC indices are recommended to be used as an affordable alternative for monitoring the effectiveness of treatment.
- 27 June 2025
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 59 (2) , 114-120
Open AccessEfficacy of liraglutide in patients with metabolic-associated steatotic liver disease in type 2 diabetes mellitus
Background. The increasing incidence of metabolism-associated steatotic liver disease (MASLD) and type 2 diabetes prompts physicians to improve strategies for the diagnosis, prevention, and treatment of these metabolic conditions. Objective: to investigate the effects of glucagon-like peptide-1 receptor agonist (arGLP-1) on the severity of metabolic disorders in patients with MASLD and type 2 diabetes mellitus in the dynamics of treatment. Materials and methods. The study included 30 patients aged (56.5 ± 7.8) years with MASLD and type 2 diabetes mellitus. They were prescribed liraglutide, a arGLP-1, with gradual titration to the maximum dose. To assess body composition, body composition analyzers TANITA BC-545N (Japan) were used. Serum levels of glucose, glycosylated hemoglobin (HbA1c), parameters of lipid and carbohydrate metabolism were determined. The atherogenic index was calculated according to the formula of W.T. Friedewald, the TyG, TyG-BMI, TyG-WC indices were calculated based on the obtained bioimpedance analysis data, as well as lipid and carbohydrate metabolism indicators. Statistical processing of the study results was carried out by methods of variation statistics using the software package StatSoft Statistica 10.0. Results. After treatment with arGLP-1, a significant decrease in serum glucose to physiological norm was observed in 26.7 % of patients, and a reduction in HbA1c levels — in 66.7 %. The therapy led to a reduction in body mass index in 28 (93.3 %) of 30 patients, in body fat percentage — in 25 (83.3 %), and the number of cases of visceral obesity decreased to 17 (56.7 %). After the use of arGLP-1, a positive trend was observed in the form of a 1.3-fold decrease in serum triglyceride levels to (1.64 ± 0.20) mmol/L versus (2.12 ± 0.25) mmol/L before treatment. Serum cholesterol, which was elevated in 11 patients, reduced in 6 cases after therapy. The use of liraglutide led to a reduction in the TyG, TyG-BMI, TyG-WC indices. Conclusions. In patients with MASLD and type 2 diabetes, treatment with liraglutide for 6 months contributed to a decrease in the amount of fat in body composition and a positive dynamics of carbohydrate and lipid metabolism. The determination of the TyG index is a useful indicator for assessing insulin resistance, and the TyG-BMI and TyG-WC indices are recommended to be used as an affordable alternative for monitoring the effectiveness of treatment.
- Open Access
- 27 June 2025
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 59 (2) , 121-128
Intraesophageal impedance-pH-manometry: general positions, clinical significance, clinical case analysis
The article describes an innovative method for diagnosing gastroesophageal reflux disease — impedance-pH monitoring. The essence of the method, the equipment for its implementation, and the rules for preparing the patient for the examination are shown. The parameters for evaluating the results are analyzed in detail. The indications for its implementation in the diagnosis of gastroesophageal reflux disease according to the Lyon Consensus 2.0 are given. A clinical case of the use of impedance-pH monitoring in a patient with suspected gastroesophageal reflux disease is analyzed in detail. Numerous graphic illustrations of the results of impedance-pH monitoring are shown, and digital monitoring indicators are evaluated.
- 27 June 2025
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 59 (2) , 121-128
Open AccessIntraesophageal impedance-pH-manometry: general positions, clinical significance, clinical case analysis
The article describes an innovative method for diagnosing gastroesophageal reflux disease — impedance-pH monitoring. The essence of the method, the equipment for its implementation, and the rules for preparing the patient for the examination are shown. The parameters for evaluating the results are analyzed in detail. The indications for its implementation in the diagnosis of gastroesophageal reflux disease according to the Lyon Consensus 2.0 are given. A clinical case of the use of impedance-pH monitoring in a patient with suspected gastroesophageal reflux disease is analyzed in detail. Numerous graphic illustrations of the results of impedance-pH monitoring are shown, and digital monitoring indicators are evaluated.
- Open Access
- 25 March 2025
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 59 (1) , 37-43
Evaluation of the state of small intestinal microbiota, pro- and anti-inflammatory cytokines, short-chain fatty acids in metabolic dysfunction-associated steatotic liver disease in patients with immune response to SARS-CоV-2
Background. The intestinal microbiota and its metabolites have a significant impact on the pathophysiology of liver diseases, it plays an important role in human metabolism, supports the intestinal mucosal barrier and interacts with the immune system. The COVID-19 epidemic has led to a significant increase in the number of patients in Ukraine suffering from metabolic dysfunction-associated steatotic liver disease (MASLD). One of the unresolved problems associated with MASLD is the identification of pathogenetic links that affect the risk of rapid progression of the disease and the development of irreversible changes in the liver. An imbalance in the intestinal microbiota is a trigger for the launch of a pathological reaction in the liver. The purpose: to study the features of the content of pro- and anti-inflammatory cytokines and short-chain fatty acids in MASLD in patients with an immune response to SARS-CoV-2 depending on the small intestinal bacterial overgrowth (SIBO). Materials and methods. The study included 61 patients with MASLD, 41 men and 20 women aged 18 to 73 years, mean age (46.4 ± 1.5) years. All patients underwent determination of IgG specific to SARS-CoV-2, cytokine content (IL-6, IL-10, TNF-α) in serum by enzyme-linked immunosorbent assay. For the diagnosis of SIBO, a hydrogen breath test (HBT) with glucose was performed. Evaluation of short-chain fatty acids in faeces was performed on a chromatograph using the Guohua Zhao method. Results. In 44.3 % of patients with MASLD and an immune response to SARS-CoV-2, SIBO was diagnosed. The median value of IL-6 level in SIBO significantly exceeded the control values by 13.7 times (p < 0.001), the median of TNF-α was significantly higher by 18.5 times (p < 0.001). In SIBO group, the levels of TNF-α and IL-6 were, accordingly, 2 (p = 0.01) and 3.3 times (p = 0.004) higher compared to patients without SIBO. The median acetic acid (C2) level in the group with SIBO statistically significantly exceeded the control value by 1.5 times (p = 0.021). The median concentration of propionic acid (C3) was significantly higher by 1.4 times (p = 0.003) in the faeces of patients with SIBO than in those without it. At the same time, in the presence of SIBO, a decrease in the median of butyric acid (C4) was observed by 2.2 times (p = 0.021) compared to the group of patients without SIBO. Direct correlations were found between the levels of IgG specific to SARS-CoV-2 and TNF-α (r = 0.304, p = 0.016); the HBT index at 45 min and the level of TNF-α (r = 0.269, p = 0.041), IL-6 (r = 0.443, p = 0.002), the median of propionic acid (C3) content (r = 0.400, p = 0.006). At the same time, an inverse correlation was found between the level of butyric acid (C4) and the HBT index at 60 min (r = –0.332, p = 0.040). Conclusions. In patients with MASLD with an immune response to SARS-CoV-2 and SIBO, there was a significant increase in the production of proinflammatory cytokines, in contrast to patients without SIBO. An increased content of acetic acid and a decrease in butyric acid in the faeces of patients with MASLD with an immune response to SARS-CoV-2 in the presence of SIBO were found. Disturbance in the microbial composition of the small intestinal microbiota, hyperproduction of proinflammatory cytokines and impaired synthesis of short-chain fatty acids are distinctive features of MASLD in patients with an immune response to SARS-CoV-2.
- 25 March 2025
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 59 (1) , 37-43
Open AccessEvaluation of the state of small intestinal microbiota, pro- and anti-inflammatory cytokines, short-chain fatty acids in metabolic dysfunction-associated steatotic liver disease in patients with immune response to SARS-CоV-2
Background. The intestinal microbiota and its metabolites have a significant impact on the pathophysiology of liver diseases, it plays an important role in human metabolism, supports the intestinal mucosal barrier and interacts with the immune system. The COVID-19 epidemic has led to a significant increase in the number of patients in Ukraine suffering from metabolic dysfunction-associated steatotic liver disease (MASLD). One of the unresolved problems associated with MASLD is the identification of pathogenetic links that affect the risk of rapid progression of the disease and the development of irreversible changes in the liver. An imbalance in the intestinal microbiota is a trigger for the launch of a pathological reaction in the liver. The purpose: to study the features of the content of pro- and anti-inflammatory cytokines and short-chain fatty acids in MASLD in patients with an immune response to SARS-CoV-2 depending on the small intestinal bacterial overgrowth (SIBO). Materials and methods. The study included 61 patients with MASLD, 41 men and 20 women aged 18 to 73 years, mean age (46.4 ± 1.5) years. All patients underwent determination of IgG specific to SARS-CoV-2, cytokine content (IL-6, IL-10, TNF-α) in serum by enzyme-linked immunosorbent assay. For the diagnosis of SIBO, a hydrogen breath test (HBT) with glucose was performed. Evaluation of short-chain fatty acids in faeces was performed on a chromatograph using the Guohua Zhao method. Results. In 44.3 % of patients with MASLD and an immune response to SARS-CoV-2, SIBO was diagnosed. The median value of IL-6 level in SIBO significantly exceeded the control values by 13.7 times (p < 0.001), the median of TNF-α was significantly higher by 18.5 times (p < 0.001). In SIBO group, the levels of TNF-α and IL-6 were, accordingly, 2 (p = 0.01) and 3.3 times (p = 0.004) higher compared to patients without SIBO. The median acetic acid (C2) level in the group with SIBO statistically significantly exceeded the control value by 1.5 times (p = 0.021). The median concentration of propionic acid (C3) was significantly higher by 1.4 times (p = 0.003) in the faeces of patients with SIBO than in those without it. At the same time, in the presence of SIBO, a decrease in the median of butyric acid (C4) was observed by 2.2 times (p = 0.021) compared to the group of patients without SIBO. Direct correlations were found between the levels of IgG specific to SARS-CoV-2 and TNF-α (r = 0.304, p = 0.016); the HBT index at 45 min and the level of TNF-α (r = 0.269, p = 0.041), IL-6 (r = 0.443, p = 0.002), the median of propionic acid (C3) content (r = 0.400, p = 0.006). At the same time, an inverse correlation was found between the level of butyric acid (C4) and the HBT index at 60 min (r = –0.332, p = 0.040). Conclusions. In patients with MASLD with an immune response to SARS-CoV-2 and SIBO, there was a significant increase in the production of proinflammatory cytokines, in contrast to patients without SIBO. An increased content of acetic acid and a decrease in butyric acid in the faeces of patients with MASLD with an immune response to SARS-CoV-2 in the presence of SIBO were found. Disturbance in the microbial composition of the small intestinal microbiota, hyperproduction of proinflammatory cytokines and impaired synthesis of short-chain fatty acids are distinctive features of MASLD in patients with an immune response to SARS-CoV-2.